Fluorescence in situ hybridization (FISH) analysis for MYC, BCL2 and BCL6 is strongly recommended in all DLBCL cases by both WHO-HAEM5 and ICC in order to identify a more aggressive subset of LBCLs. This evidence concerns the gene MYC and intrahepatic cholangiocarcinoma.